Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing periarticular vasoconstrictor infiltration and erector spinae plane block to reduce bleeding and pain in lumbar fusion

Official title: EFFICACY OF PERIARTICULAR VASOCONSTRICTOR INFILTRATION (PVI) VERSUS ERECTOR SPINAE PLANE BLOCK (ESP) IN REDUCING BLEEDING AND POSTOPERATIVE PAIN CONTROL IN LUMBAR FUSION SURGERY: RANDOMIZED CLINICAL TRIAL.

Run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · NCT07550114 · Data updated 2026-11-12

This trial will try periarticular vasoconstrictor infiltration versus erector spinae plane block to see if one reduces blood loss and postoperative pain in adults having lumbar fusion surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment62 (estimated)
SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Academic / other
Locations2 sites (Barcelona, Barcelona and 1 other locations)
StatusRecruiting
StartedJanuary 8, 2026
Main results expectedJanuary 8, 2028
Study endsMarch 1, 2028
Registry record updatedApril 24, 2026
Trial IDNCT07550114 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with ASA I–III scheduled for primary lumbar or thoracolumbar fusion who can provide informed consent and are not on high-dose chronic opioids are ideal candidates.

Probably not a fit

Patients with contraindications such as allergy to study drugs, coagulopathy, infection at the block site, neuromuscular disease affecting assessment, chronic high-dose opioid use, cognitive impairment, or pregnancy are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized 1:1 multicenter trial enrolling adults undergoing primary lumbar or thoracolumbar fusion (up to three levels) at two hospitals in Spain. Participants receive ultrasound-guided ropivacaine 0.2% with epinephrine either as a high-volume periarticular vasoconstrictor infiltration (PVI) in multiple tissue planes or as a standard erector spinae plane (ESP) block (20 mL per side), with both groups managed under standardized general anesthesia, multimodal analgesia, and tranexamic acid. The primary outcome is intraoperative blood loss measured by surgical aspirate minus irrigation plus gravimetric gauze weight; secondary outcomes include surgical field quality, pain scores at multiple time points, and opioid consumption. The trial enrolls about 62 patients across Hospital de la Santa Creu i Sant Pau (Barcelona) and Hospital Quirón Salud Murcia (Murcia).

Why it matters

Potential benefit: If successful, the preferred technique could lower intraoperative bleeding and postoperative pain, potentially reducing transfusions and opioid needs.

How similar studies have gone: Erector spinae plane blocks have supportive evidence for postoperative analgesia, PVI is a promising high-volume vasoconstrictive approach based on WALANT principles, and there are no prior randomized head-to-head trials comparing PVI versus ESP in lumbar fusion.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* More than 18 years old.
* ASA I-III
* Scheduled primary spinal instrumentation surgery (lumbar/thoracolumbar fusion)
* Signed informed consent

Exclusion Criteria:

* Allergy/contraindication to study drugs (ropivacaine, epinephrine)
* Coagulopathy.
* Infection at block site
* Neuromuscular disease affecting evaluation.
* Chronic opioid use (\>30mg morphine equivalents/day)
* Cognitive impairment preventing pain reporting.
* Pregnancy

Where it's running

  • Hospital de la Santa Creu i Sant Pau
    Barcelona, Barcelona, Spain
    Recruiting
  • Hospital Quiron Murcia
    Murcia, Murcia, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.